About us

Professor Fishel began his research in Cambridge with the late Professor Sir Robert Edwards, CBE, FRS Nobel Laureate several years before the birth of the first IVF baby in 1978. He is one of the world’s most eminent specialists in the field of fertility treatment. He is recognized for his pioneering work in embryology and IVF, received numerous international awards for his work in the field of assisted reproduction, published over 200 papers and edited 4 books on the development of IVF and micromanipulation technology. Simon Fishel is chairman of FutureLife scientific advisory board.

Paul Serhal is an accredited consultant in Reproductive Medicine and is a Fellow of the Royal College of Obstetricians and Gynaecologists. He was a Clinical Lecturer in Obstetrics and Gynaecology at University College London Hospital. His vast experience of male and female infertility has ensured that CRGH is amongst world-class leaders in the pioneering of new techniques, such as pre-implantation genetic diagnosis and the advancement of fertility treatments. Mr Serhal has published more than 100 articles in books and journals and frequently lectures at international conferences.

MUDr. Štěpán Machač, Ph.D. was born in 1970. He graduated from the Palacký University of Medicine in Olomouc. From 1995 – 2003 he worked at the Gynaecology and Obstetrics Clinic of Faculty of Medicine and Dentistry at Palacký University Olomouc and started to deal with infertility treatment. In 2006, he obtained a Ph.D. degree, after defending his dissertation on ovarian hyper stimulation syndrome and congenital thrombophilia. In the years 2006 – 2014, he worked at the Reprofit International clinic as the lead IVF physician for foreign patients. Since 2014 he has been acting as a head of the IVF Clinic in Olomouc. In 2018 he was appointed as a Future Life CMO.

He has authored or co-authored more than 30 lectures and 40 articles in professional journals. In his work he focuses mainly on the issue of assisted reproduction, ovarian hyperstimulation syndrome and gamma donation.

Director of Institut Marquès since the 2000’s, she´s member of the Governing Board of Sterility and Infertility Section of the Spanish Society for Gynaecologists, member of the National Commission of the Spanish Ministry of Health for Gamete Donors and member of the National Commission of the Spanish Ministry of Health, responsible of the National Biovigilance System.Degree in Medicine and Surgery, she specialised in Obstetrics and Gynaecology. According to the platform Research Gate, Dr López-Teijón appears among the top 10% of the most relevant researchers in the world. She divides her time between Institut Marquès’s General Management, the consultation and the Research and Development Project Team. Dr López-Teijón has been a pioneer in the study of male fertility and oestrogen disruptors. Also she created the first embryo adoption programme in 2004.

Recognised for her R&D work about the effects of music at the beginning of life: she is developing an important line of research about the effects of the musical micro-vibrations in the incubators during embryo development, thereby increasing the rate of in-vitro-fertilisation by 5%. In this field, she is the lead researcher of the study “Fetal facial expression in response to intravaginal music emission” the most downloaded study in Ultrasound, the journal of the British Medical Ultrasound Society (BMUS). She received the 2017 Ig Nobel Prize in Medicine for this work, the first in Obstetrics in the 27-year history of the prize (Harvard University, September 2017).

She is also the author of the blog “fertility-experiences.com“, with more than 850,000 readers. Her book “I want to get pregnant now!” published in English, Spanish and Italian has become an essential fertility guide.

MUDr. (MD) Ladislav Zgabur is a graduate of the Medical Faculty at Charles University and the Military Medical Research and Training Institute at Jan Purkyně University in Hradec Králové, field of General Medicine. He began working in health care management positions in 1990. He worked as the Administrative Director managing healthcare, the spa industry, and recreation for the Federal Ministry of the Interior of the Czechoslovak Federal Republic until 1992. He was one of the founders of the Health Insurance Company of the Ministry of the Interior and its first health director. Between 1995 and 2002, he acted in management positions at the Ministry of Health of the Czech Republic and at the VZP health insurance company. He began working on many private sector health care projects in 2002, and was chiefly involved in the consolidation of laboratories in the Czech Republic and Slovakia. He was also a major participant in the origin and development of the FUTURE LAB (now SYNLAB) Group and the AESKULAB Holding. In 2014, he prepared the FutureLife Group project, which he achieved in close cooperation with the HARTENBERG Company. He is currently involved in specialist management and other acquisitions for the FutureLife Company.